ARCHIVES

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

This article is from The Cancer Letter archive.

Vol. 32 No. 46 | December 22, 2006

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

Senate Committee Ok’s $1.9 Billion Budget For NCI, Same As House Appropriation

July 29, 1994

Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.

March 31, 2000

Duke Scientists Develop 3D Mammography Using CT

February 24, 2006

Breast cancer session was ASCO equivalent of a rock concert, discussant says.

May 27, 2005

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007